Basic information
- Standard SMILES
CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1- InChIKey
VSZGPKBBMSAYNT-RRFJBIMHSA-N- Molecular formula
- C16H28N2O4
- Average molar mass
- 312.4 g/mol
- Monoisotopic mass
- 312.20490738
Names & identifiers
- Preferred name
- Oseltamivir
- IUPAC
- ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
- English name
- Oseltamivir
- Molecular formula
- C16H28N2O4
- Molecular weight
- 312.4
Names & synonyms
Show more names
Database identifiers
- CAS
196618-13-0、204255-11-8- PubChem CID
- 65028
- DTXSID
DTXSID9044291- ChEMBL
CHEMBL1229- ChEBI
CHEBI:7798- UNII
- 20O93L6F9H
- Nikkaji
- J871.765F
Properties
Computed structural properties
- XLogP
- 1.1
- Topological polar surface area
- 90.7 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 8
- Heavy atoms
- 22
- Formal charge
- 0
- Complexity
- 418
Physicochemical properties
- Melting point
- 107 · 107-108 °C
- Boiling point
- 473.3 · 473.3±45.0 °C(Predicted)
- Density
- 1.08 · 1.08±0.1 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C(protect from light)
- solubility
- Chloroform (Sparingly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
- pka
- 7.7 · 7.7 (25°); 6.6 (70°)
- form
- Solid
- color
- Off-White to Pale Beige
- Henry's Law Constant
- 3.4 · 3.4×1010 mol/(m3Pa) at 25℃, HSDB (2015)
- Stability
- Hygroscopic
- InChI
- InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1
- InChIKey
- VSZGPKBBMSAYNT-RRFJBIMHSA-N
- SMILES
- C1(C(OCC)=O)C[C@H](N)[C@@H](NC(C)=O)[C@H](OC(CC)CC)C=1
- CAS DataBase Reference
- 196618 · 196618-13-0
- NCI Dictionary of Cancer Terms
- Tamiflu
- FDA UNII
- 20 O93L6F9H · 20O93L6F9H
- NCI Drug Dictionary
- Tamiflu
- ATC code
- 5 AH02 · J05AH02
- EPA Substance Registry System
- 1 · 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- (196618-13-0)
- Protein binding
- 42 · 42 (3 as carboxylate)
- Excreted unchanged in urine
- Negligible (99% excreted as carboxylate metabolite in urine)
- Volume of distribution
- 0.3 · 0.3-0.4(L/kg)
- Biological half-life
- 1 · 1-3, (6-10 as metabolite) / >20
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302-H315-H319-H335
- Precautionary statements
- 261 · P261-P301+P312-P302+P352-P304+P340-P305+P351+P338
- Hazardous Substances Data
- 196618 · 196618-13-0(Hazardous Substances Data)
Safety & regulation
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H302-H315-H319-H335
- Precautionary statements
- P261-P301+P312-P302+P352-P304+P340-P305+P351+P338
- Hazardous Substances Data
- 196618-13-0(Hazardous Substances Data)
Chemistry & industry
Applications
DescriptionOseltamivir is a drug that suppresses the action of influenza A, influenza B, and H1N1 influenza viruses in children and adults. Oseltamivir is administered for the treatment of influenza (flu) for people who are above the age of 2 weeks and have been experiencing flu-like symptoms for less than two days. Oseltamivir may also be prescribed for people who are above 1-year-old as a protective measure to prevent them from contracting influenza due to exposure to the virus without necessarily having indicated any symptoms of infection. The drug may not treat common cold. Oseltamivir goes by the brand name Tamiflu.
UsesOseltamivir is an orally active inhibitor of influenza virus neuraminidase; converted in vivo to the active acid metabolite. An antiviral drug. It is a COVID19-related research product.
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers50 total
Additional notes
DefinitionChEBI: A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza.
Related reactions
Linked notes
Loading…